We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+3.47%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$405B
AUM Growth
+$3.26B
Cap. Flow
-$4.73B
Cap. Flow %
-1.17%
Top 10 Hldgs %
17.59%
Holding
10,501
New
1,231
Increased
3,688
Reduced
4,131
Closed
1,043

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$1.12B
2
AAPL icon
Apple
AAPL
+$1.08B
3
MSFT icon
Microsoft
MSFT
+$1.05B
4
NKE icon
Nike
NKE
+$1.03B
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$821M

Sector Composition

Rank Sector Weight
1 Technology 17.8%
2 Financials 8.25%
3 Healthcare 6.4%
4 Consumer Discretionary 5.85%
5 Communication Services 4.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACA icon
2851
Arcosa
ACA
$7.11B
$5.14M ﹤0.01%
61,620
+8,333
+16% +$694K
EQAL icon
2852
Invesco Russell 1000 Equal Weight ETF
EQAL
$838M
$5.14M ﹤0.01%
115,084
-9,909
-8% -$445K
HTGC icon
2853
Hercules Capital
HTGC
$3.23B
$5.13M ﹤0.01%
250,994
-2,431
-1% -$46.8K
MPT
2854
Medical Properties Trust
MPT
$2.81B
$5.12M ﹤0.01%
1,189,030
-493,299
-29% -$2.36M
OCUL icon
2855
Ocular Therapeutix
OCUL
$2.02B
$5.12M ﹤0.01%
748,733
+265,227
+55% +$1.64M
VNT icon
2856
Vontier
VNT
$4.74B
$5.12M ﹤0.01%
134,004
+23,169
+21% +$934K
SOHU
2857
Sohu.com
SOHU
$357M
$5.11M ﹤0.01%
367,197
-2,418
-0.7% -$29.1K
IPAC icon
2858
iShares Core MSCI Pacific ETF
IPAC
$2.77B
$5.11M ﹤0.01%
83,444
+1,744
+2% +$107K
SWTX
2859
DELISTED
SpringWorks Therapeutics
SWTX
$5.11M ﹤0.01%
135,604
-77,929
-36% -$3.28M
GTM
2860
CALL
ZoomInfo Technologies
GTM
$1.22B
$5.11M ﹤0.01%
400,000
+332,700
+494% +$4.65M
ESNT icon
2861
Essent Group
ESNT
$6.33B
$5.1M ﹤0.01%
90,815
-80,489
-47% -$4.48M
ECL icon
2862
CALL
Ecolab
ECL
$79.9B
$5.09M ﹤0.01%
21,400
-3,600
-14% -$832K
ECL icon
2863
PUT
Ecolab
ECL
$79.9B
$5.09M ﹤0.01%
21,400
-3,600
-14% -$832K
SNAP icon
2864
PUT
Snap
SNAP
$9.01B
$5.08M ﹤0.01%
306,000
-759,400
-71% -$10.9M
NICE icon
2865
Nice
NICE
$5.97B
$5.06M ﹤0.01%
29,446
+10,818
+58% +$2.23M
HTO
2866
H2O America
HTO
$2.62B
$5.06M ﹤0.01%
93,257
+2,014
+2% +$110K
RHP icon
2867
Ryman Hospitality Properties
RHP
$7.63B
$5.05M ﹤0.01%
50,617
-41,919
-45% -$4.42M
XHB icon
2868
CALL
State Street SPDR S&P Homebuilders ETF
XHB
$1.56B
$5.05M ﹤0.01%
50,000
-400,800
-89% -$41.9M
VTWV icon
2869
Vanguard Russell 2000 Value ETF
VTWV
$1.31B
$5.05M ﹤0.01%
37,696
-2,730
-7% -$368K
CCRN
2870
DELISTED
Cross Country Healthcare
CCRN
$5.05M ﹤0.01%
364,912
+337,214
+1,217% +$5.34M
NVEI
2871
DELISTED
Nuvei Corporation Subordinate Voting Shares
NVEI
$5.03M ﹤0.01%
155,366
+137,053
+748% +$4.41M
BIP icon
2872
Brookfield Infrastructure Partners
BIP
$18B
$5.03M ﹤0.01%
183,301
+33,363
+22% +$950K
AL
2873
DELISTED
Air Lease Corp
AL
$5.03M ﹤0.01%
105,772
+52,402
+98% +$2.55M
RNG icon
2874
RingCentral
RNG
$5.28B
$5.01M ﹤0.01%
177,683
+49,571
+39% +$1.59M
MLN icon
2875
VanEck Long Muni ETF
MLN
$683M
$5.01M ﹤0.01%
280,303
+38,621
+16% +$688K

Similar funds

UBS Group's Q2 2024 Portfolio in Review

As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

UBS Group's Q2 2024 filing shows 1,231 new, 3,688 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
  • UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
  • UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
  • UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
  • UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
  • UBS Group opened 1,231 new positions and closed 1,043 in Q2 2024.
  • UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.

Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.